You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PEG-IFNa-2a

Showing 1 - 25 of 3,592
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia Trial in Poitiers (Imatinib mesylate 400 mg, Imatinib mesylate 600 mg, Imatinib 400 mg +

Completed
  • Chronic Myeloid Leukemia
  • Imatinib mesylate 400 mg
  • +3 more
  • Poitiers, France
    University Hospital
Apr 10, 2020

Colonoscopy Trial in Chendu (100 ml lactulose combined with 1 L PEG, 100 ml lactulose combined with 2 L PEG, 200 ml lactulose)

Completed
  • Colonoscopy
  • 100 ml lactulose combined with 1 L PEG
  • +3 more
  • Chendu, Sichuan, China
    west china fourth hospital of Sichuan university
Dec 29, 2022

Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +2 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023

Nonalcoholic Steatohepatitis (NASH) Trial in Taiwan (ADI-PEG20, Placebo)

Not yet recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Kaohsiung, Taiwan
  • +4 more
Apr 24, 2023

Soft Tissue Sarcoma, Sts, Sarcoma,Soft Tissue Trial in Saint Louis (ADI PEG20, Ifosfamide, Radiotherapy)

Not yet recruiting
  • Soft Tissue Sarcoma
  • +2 more
  • ADI PEG20
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 2, 2023

Peripheral Nerve Injuries Trial in United States (NTX-001)

Not yet recruiting
  • Peripheral Nerve Injuries
  • Baltimore, Maryland
  • +6 more
Jul 27, 2022

Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)

Not yet recruiting
  • Chronic Hepatitis B
  • PEG IFN α-2b; TAF
  • (no location specified)
Aug 5, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Biopsy
  • +7 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 23, 2023

Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)

Recruiting
  • Hepatitis B, Chronic
  • PEGylated recombinant human interferon alpha-2b injection
  • Hefei, Anhui, China
    The First Affiliated Hospital of Anhui Medical University
Jun 24, 2023

1L-PEG-Asc Solution for Bowel Preparation in"Open Access"

Completed
  • Bowel Preparation
  • use of a very low-volume 1L-PEG plus ascorbate (plenvu) or low-volume 2L-PEG plus ascorbate (moviprep) for bowel preparation in open access colonoscopy
  • Carpi, Modena, Italy
    Azienda USL Modena
Feb 15, 2022

Hepatitis B, Chronic Trial in Guangzhou (ASC42 10mg, ASC42 15mg, ih PEG-IFN a-2a)

Recruiting
  • Hepatitis B, Chronic
  • ASC42 10mg
  • +4 more
  • Guangzhou, Guangdong, China
    NanFang Hospital of Southern Medical University
Jan 13, 2022

Chronic Hepatitis B Virus Infection Trial in Worldwide (PEG-IFNa, BRII-835)

Not yet recruiting
  • Chronic Hepatitis B Virus Infection
  • Kingswood, New South Wales, Australia
  • +28 more
Jul 21, 2023

Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)

Not yet recruiting
  • Chronic Hepatitis b
  • +2 more
  • Anti-PD-1 antibody
  • +2 more
  • Chongqing, Chongqing, China
    The 2nd affiliated Hospital of Chongqing Medical University
Mar 14, 2023

B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Lymphoblastic Lymphoma Trial

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • +5 more
  • Biospecimen Collection
  • +4 more
  • (no location specified)
Oct 28, 2022

Hepatitis B, Chronic Trial in Worldwide (VIR-2218, VIR-3434, PEG-IFNa)

Recruiting
  • Hepatitis B, Chronic
  • San Francisco, California
  • +39 more
Oct 3, 2022

Acute Myeloid Leukemia Trial in Ann Arbor (peg-IFN-a, Hematopoietic Cell Transplant (HCT), Tacrolimus)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Oct 1, 2021

Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

Recruiting
  • Polycythemia Vera
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
May 19, 2023

Tumor, Colorectal Cancer Trial in United States (NKTR-102 100 mg/m2, NKTR-102 125 mg/m2, Cetuximab)

Completed
Has Results
  • Tumor
  • Colorectal Cancer
  • NKTR-102 100 mg/m2
  • +2 more
  • Scottsdale, Arizona
  • +3 more
Jul 9, 2021

Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)

Completed
Has Results
  • Juvenile Pilocytic Astrocytomas
  • Optic Pathway Gliomas
  • Pegylated interferon alpha-2b
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Jan 18, 2022

Mesothelioma Trial in Worldwide (ADI-PEG 20 plus Pem Cis, Placebo plus Pem Cis)

Completed
  • Mesothelioma
  • ADI-PEG 20 plus Pem Cis
  • Placebo plus Pem Cis
  • Phoenix, Arizona
  • +44 more
Sep 30, 2022

Hepatitis B, Chronic Trial in Shanghai (hepalatide, Pegylated Interferon, TAF)

Not yet recruiting
  • Hepatitis B, Chronic
  • Shanghai, Shanghai, China
    Shanghai Tong Ren Hospital
Nov 12, 2021

Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,

Completed
Has Results
  • Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood B-Lymphoblastic Lymphoma
  • San Diego, California
  • +2 more
Sep 13, 2022

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

Active, not recruiting
  • Brain Tumor
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 20, 2022

Oral Cancer Trial in Cairo (Quercetin 3,3',4',5,6-Pentahydroxyflavone,

Not yet recruiting
  • Oral Cancer
  • Quercetin 3,3',4',5,6-Pentahydroxyflavone, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one
  • +2 more
  • Cairo, Egypt
    11 Saraya El Manial
Jul 8, 2022

Advanced Cholangiocarcinoma Trial in Washington (Pembrolizumab, Sylatron)

Terminated
Has Results
  • Advanced Cholangiocarcinoma
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Feb 14, 2022